We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+28.59%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$641M
AUM Growth
+$1.48M
(+0.23%)
Cap. Flow
-$73.7M
Cap. Flow
% of AUM
-11.5%
Top 10 Holdings %
Top 10 Hldgs %
74.67%
Holding
104
New
37
Increased
11
Reduced
24
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$3.25M |
| 2 |
Immunovant
IMVT
|
+$2.46M |
| 3 |
Micron Technology
MU
|
+$1.91M |
| 4 |
PayPal
PYPL
|
+$1.88M |
| 5 |
Ollie's Bargain Outlet
OLLI
|
+$1.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MOMO
Hello Group
MOMO
|
+$3.06M |
| 2 |
Sea Limited
SE
|
+$1.9M |
| 3 |
e.l.f. Beauty
ELF
|
+$1.75M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.71M |
| 5 |
Alibaba
BABA
|
+$1.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.97% |
| 2 | Consumer Discretionary | 3.87% |
| 3 | Technology | 2.77% |
| 4 | Communication Services | 2.75% |
| 5 | Consumer Staples | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DQ
51
Daqo New Energy
DQ
$930M
| $1.01M | 0.16% |
98,510
-70,000
| -42% | -$595K |
|
52
Snap
SNAP
$8.48B
| $980K | 0.15% |
+60,000
| New | +$883K |
|
53
Aquestive Therapeutics
AQST
$476M
| $932K | 0.15% |
+160,099
| New | +$833K |
|
54
RingCentral
RNG
$4.81B
| $932K | 0.15% |
5,525
| – | – |
|
55
KraneShares CSI China Internet ETF
KWEB
$5.69B
| $910K | 0.14% |
18,700
-33,000
| -64% | -$1.51M |
|
56
Axogen
AXGN
$2.46B
| $895K | 0.14% |
50,000
| – | – |
|
|
MOTS
57
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $763K | 0.12% |
1,111
| – | – |
|
|
SPPI
58
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $728K | 0.11% |
+200,000
| New | +$1.62M |
|
59
Vipshop
VIPS
$7.47B
| $709K | 0.11% |
50,000
| – | – |
|
60
NVIDIA
NVDA
$5.01T
| $706K | 0.11% |
+120,000
| New | +$624K |
|
61
Afya
AFYA
$1.3B
| $656K | 0.1% |
24,200
-5,000
| -17% | -$135K |
|
62
Vicor
VICR
$9.85B
| $645K | 0.1% |
+13,800
| New | +$526K |
|
63
Bilibili
BILI
$8.05B
| $616K | 0.1% |
33,100
-60,900
| -65% | -$989K |
|
64
NetEase
NTES
$84.2B
| $613K | 0.1% |
+10,000
| New | +$586K |
|
65
New Oriental
EDU
$9.4B
| $606K | 0.09% |
5,000
-1,000
| -17% | -$120K |
|
|
LX
66
LexinFintech Holdings
LX
$242M
| $600K | 0.09% |
43,201
-101,700
| -70% | -$1.17M |
|
|
AKTS
67
DELISTED
Akoustis Technologies Inc
AKTS
| $600K | 0.09% |
+75,000
| New | +$586K |
|
|
INFN
68
DELISTED
Infinera Corporation Common Stock
INFN
| $397K | 0.06% |
+50,000
| New | +$307K |
|
|
CYOU
69
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $381K | 0.06% |
38,967
| – | – |
|
70
Stoke Therapeutics
STOK
$1.84B
| $374K | 0.06% |
13,200
-3,800
| -22% | -$95.6K |
|
71
Enphase Energy
ENPH
$5.2B
| $366K | 0.06% |
+14,000
| New | +$319K |
|
72
Melco Resorts & Entertainment
MLCO
$2.17B
| $363K | 0.06% |
+15,000
| New | +$326K |
|
|
APLT
73
DELISTED
Applied Therapeutics
APLT
| $325K | 0.05% |
+11,901
| New | +$204K |
|
74
Voyager Therapeutics
VYGR
$181M
| $246K | 0.04% |
+17,650
| New | +$257K |
|
75
Qfin Holdings
QFIN
$1.69B
| $244K | 0.04% |
+25,000
| New | +$226K |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Granite Point Capital Management held 104 positions worth $641M, up 0.23% from $639M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Granite Point Capital Management withdrew a net $73.7M in Q4 2019, closing 16 positions and reducing 24 holdings. Its most notable exit was e.l.f. Beauty, an estimated $1.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6% of assets, up from 3.5% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Granite Point Capital Management opened a new position in Bristol-Myers Squibb Company Contingent Value Rights worth $3.76M.
- Granite Point Capital Management's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 1,250,000 shares worth $3.76M.
- Granite Point Capital Management added most to CareDx in Q4 2019, an estimated $1.23M increase.
- Granite Point Capital Management's biggest Q4 2019 reduction was Hello Group, cutting an estimated $3.06M.
- Granite Point Capital Management fully exited e.l.f. Beauty in Q4 2019, selling an estimated $1.75M.
- Granite Point Capital Management's ten largest holdings make up 75% of its $641M portfolio in Q4 2019.
- Granite Point Capital Management opened 37 new positions and closed 16 in Q4 2019.
- Granite Point Capital Management's portfolio value rose 0.23% quarter-over-quarter to $641M.
Based on Granite Point Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.